Due to the lack of similar data in real life and the lack of sufficient evidence in the literature on this subject, we hypothesized that the pretransfusion Hb threshold affects the annual EC transfusion burden (in units and sessions) in thalassemia and MDS patients. This evidence concerns the gene GSTM1 and myelodysplastic syndrome.